Transplantable colonic adenocarcinomas in rats

Area of Science:

• Oncology
• Gastroenterology
• Carcinogenesis

Background:

• Dimethylhydrazine (DMH) is a chemical carcinogen used to induce experimental colon cancer.
• Understanding the mechanisms and routes of metastasis is crucial for developing effective cancer therapies.

Purpose of the Study:

• To investigate the effect of different dimethylhydrazine (DMH) exposure durations on the induction of colonic adenocarcinoma and metastasis in Fischer F344 rats.
• To characterize the route of metastasis and the cellular origin of malignant ascites.

Main Methods:

• Fischer F344 rats were administered weekly doses of DMH (20 mg/kg) for either 15 or 20 weeks.
• Tumor development and metastatic patterns were monitored.
• Malignant ascites cells were analyzed using immunofluorescence and electron microscopy.
• Transplantation of ascites cells into syngeneic rats was performed.

Main Results:

• Rats exposed to DMH for 20 weeks developed primary colonic tumors with metastases, whereas 15-week exposure resulted in primary tumors only.
• Transcoelomic spread was the predominant route of metastasis, frequently associated with ascites.
• Immunofluorescence and electron microscopy confirmed the epithelial origin of malignant ascites cells.
• Transplanted ascites cells formed adenocarcinomatous metastases, confirming their malignant potential.

Conclusions:

• The duration of DMH exposure significantly influences the development of metastasis in experimental colonic adenocarcinoma.
• Transcoelomic spread is a key mechanism for metastasis in this model, with malignant ascites cells being of epithelial origin.
• This rat model provides valuable insights into colon cancer metastasis and the behavior of malignant ascites.